RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 One-Year Results from the AMPLE Study
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 9
SP 7
OP 7
DO 10.1177/155989771209003
UL http://mdc.sagepub.com/content/12/9/7.abstract
AB To date, no randomized, controlled studies have directly compared the safety and efficacy of different biologic disease-modifying antirheumatic drugs in rheumatoid arthritis (RA). This article presents the 1-year results of the Abatacept Versus Adalimumab Comparison in Biologic-Naïve RA Subjects With Background Methotrexate study [AMPLE; NCT00929864], that compared the efficacy and safety of subcutaneous abatacept versus adalimumab, both with background methotrexate.